FDA Announces Stronger Warning for Benzodiazepines
The Food and Drug Administration (FDA) announced in September 2020 that it would require a new warning label for a class of psychiatric drugs called benzodiazepines in order to better inform the public and health professionals about the serious risks of misuse and addiction. Benzodiazepines—sometimes referred to as “benzos”—are commonly prescribed for anxiety, insomnia, seizures,… Continue Reading FDA Announces Stronger Warning for Benzodiazepines